SlideShare una empresa de Scribd logo
1 de 30
Skmarina Hanna Larose S.
P. Vesper J. N. Zamili
Adolf Finsensius Sarumaha
Agnes Meinulo Duha
Alhoi Lesley Davidson
Annisa Maichie Kurniasih
Evie Clarensia Lase
Louis Mapolo Sutian
Maruli Freddy Simamora
Nikko Fernando Venesia
Nita Fatmasari Bangun
Rosnilam Moho
Siti Ramadhani
Sri Wahyu Ratnasari
Nasution
Tiorasi Pakpahan
Adi, a six-year-old-boy, can’t take school activities in his school for
six days because of having severe fever, myalgia and anorexia,
but lately, Adi’s face comes paler, his heart beats faster, malaise,
lose appetite, bleeding around his gums and petechiae,
ecchymosis in superficial. Adi has history of eating Chlorampenicol
often and antipiretic which are bought by his mother. Hence Adi’s
condition is worse, Adi is taken to pediatrician. Doctor suggests to
do a complete blood examination and Bone Marrow Punction.
What has happened to Adi and how is the management?
• Myalgia : pain on muscle
• Ecchymosis : patch of bleeding under skin with diameter > 2
mm
• Petechiae : patch of bleeding under skin with diameter < 2 mm
• Anorexia : appetite disruption
• Bone Marrow Punction : an examination by doing aspiration of
bone marrow liquid
1. Adi, a six-year-old-boy, can’t take school activities in his
school for six days because of having severe fever, myalgia
and anorexia, but lately, Adi’s face comes paler, his heart
beats faster, malaise, lose appetite, bleeding around his gums
and petechiae, ecchymosis in superficial.
2. Adi has history of eating Chlorampenicol often and antipiretic
which are bought by his mother.
3. Doctor suggests to do a complete blood examination and
Bone Marrow Punction.
1. - Probably caused by infection
- Probably caused by aplastic anemia
- Patient has hemostatic disfunction
- Probably having thrombosis disfunction
- Probably having pancytopenia
2. - Probably caused by toxin of medicines
- Lack of knowledge of patient’s mom
3. To uphold the final diagnose
Adi, a-six-year-old-boy, probably is having
anemia aplastic
1. Classification of anemia
2. Definition of aplastic anemia
3. Etiology of aplastic anemia
4. Epidemiology of aplastic anemia
5. Classification of aplastic anemia
6. Pathophysiology of aplastic anemia
7. Clinical symptoms of aplastic anemia
8. Anamnesis of aplastic anemia
9. Physical examination of aplastic anemia
10. Supporting examination of aplastic anemia
11. Management of aplastic anemia
12. Prevention of aplastic anemia
13. Complication of aplastic anemia
14. Prognosis of aplastic anemia
A. Based on etiopathogenesis
I. Disturbance in erythrocytes formation and marrow bone
a. Deficiency of essential
a. Iron Deficiency
b. Folic acid deficiency
c. Vitamin B12 deficiency
b. Disturbance in Iron utilization
a. Chronic disease
b. Sideroblastic anemia
c. Marrow bone destruction
a. Aplastic anemia
b. Mieloptisica anemia
c. Hematologic anemia
d. Dyserythropoiesis anemia
e. Myelodisplastic syndrome
d. Deficiency of erithropoiesis
II. Hemorrhagic cause
III. Hemolitic cause
IV. Unknown and complex pathogenesis
B. Based on morphology
I. Hypochromic microcytic
II. Normochromic normocytic
III. Macrocytic
a. Megaloblastic
b. Non-megaloblastic
Aplastic anemia is a condition caused by decreasing of
peripheral blood hematopoietic cells such as erythrocytes,
leukocytes and platelets as a result of the cessation of cell
production in bone marrow hemopoetic.
a. Congenital Factor : Fanconi syndrome
b. Acquired factors :
• Chemicals : Benzene, insecticides, compound As, Au, Pb.
• Drugs : Chloramphenicol, mesantoin (anticonvulsants),
piribenzamin (antihistamines ), santonin - calomel, a drug
sitostatica (myleran, methrotrexate, TEM, vincristine,
rubidomycine etc. ), anti- tumor drugs (nitrogen mustard),
anti- microbial.
• Radiation : Roentgen rays, radioactive.
• Infection : Miliary tuberculosis, hepatitis and others - others.
• Malignancy : Kidney disease, endocrine disorders, and
idiopathic.
The incidence of acquired aplastic anemia varies around the
world and range from 2 to 6 cases per 1 million population per
year with geographic variation. Acquired aplastic anemia
generally appears at the age of 15 to 25 years; peak incidence
appears after the age of 60 years.
I. Primary
1 . Congenital abnormalities
2 . Idiopathic
II . Secondary :
1 . Due to radiation, chemicals, or drugs
2 . Due to other causes :
a. Virus Infection : Hepatitis Viruses / other viruses
b . Due to pregnancy
c . Radiation
1. Tachycardia
2. Increasing of breathing frequency
3. Pale
4. Weakness
5. Dizzy
6. Nausea
7. Decreasing quality of skin and hair
a. Complaints eritroblastopenia
b. Complaints thrombocytopenia
c. Complaints eukopenia
d. History of treatment :
• Consume drugs in a long period of time
• Chemotherapy
• Often exposed to radiation like x-rays and radioactive
rontgen
e. previous Illness History
d. Family history of sitopenia
a. Inspection :
1. Pale
2. There are bruises, petechiae, or ecchymosis
3. bleeding gums
b. Palpation :
1. body temperature increase
2. cold extremities
3. tachicardy
4. Hepatomegaly (found in a several patients)
c. Percussion :
Hepatomegaly (found in a fraction of patients)
d. Auscultation :
gallop rhytm and wheezing
1. Laboratory Examination
a. Peripheral Blood
According to The International Agranulocytosis and Aplastic
Anaemia Study (IAAS) is called anemia aplastik when:
i. the levels of hemoglobin ≤ 10 g/dl or Hematokrit ≤ 30%
ii. Count of platelets ≤ 50,000/mm3
iii. Leukocyte Count ≤ 3500/mm3 or Granulocytes ≤ 1.5 ×
109/l
2. bone marrow Biopsy
3. Radiological Examination
1. Nuclear Magnetic Resonance Imaging
2. Radionuclide Bone Marrow Imaging (Scanning Bone
Marrow)
Diagnosis differential
1. Idiopathic Thrombocytopenic Purpura (ITP) and
Thrombocytopenic Purpura Amegakaryocytic (ATP)
2. Type of aleukemik acute Leukemia, especially ALL
(Acute Lymphocytic Leukemia)
3. Preleukemik Stage of acute leukemia
Management
1. Supportive therapy
1. Leukocyte-poor red cells Transfusion (overcome anemia)
2. Platelet suspension transfusion (Overcome bleeding)
3. Antibiotics ( for infections, recommended antibiotics are b-lactam and
aminoglycosides)
4. Blood, urine, faeces, sputum, CSF culture
5. Avoiding the chemical and physical toxic and drugs.
2. Medication Therapy
1. Androgen
Oksimetolon is better instead of testosteron, with dose 1-2
mg/kg/day
2. Imunosuppressive
a. Methylprednisolon ( 5 mg/kg IV 8 days then tappering)
b. Antilymphocyte-Globulin (40mg/kg IV for 12hours
+methylprednisolon 1mg/kg/hours IV for 4 days)
c. Antithymocyte-Globulin (100-2000mg/kg IV)
d. Cyclosporin A (8mg/kg/day PO for 14 day continue with
15mg/kg/day)
e. Cyclophosphamide (50mg/kg/day for 4 days, still
controversy)
3. Growth factor ( G-CSF with dose 5 ig/kg/day)
4. Combination therapy
combination of ALG/ATG, methylprednisolon and CsA.
3. Blood Transfusion
4. Chelation Therapy
given when there is accumulation of iron due to blood transfusion
5. bone marrow transplant
6. Food
7. Rest
Relaps
in case of relaps then can be given CsA and if unsuccessful then can
be given repeat ATG
Prevention
1. Avoiding toxic materials
2. Avoiding drugs consumption which can trigger aplastic anemia
3. Avoiding radiation
4. Good hygiene
5. Management of bleeding and infection
1. Infection
2. Bleeding
3. GVHD after transplantation
4. Death
Based on :
1. Bone Marrow representation
2. HbF > 200 mg% give a better prognosis
3. Granulocyte > 2000/mm3 give better prognosis
4. Secondary infection prevention
Diagnose : Adi, 6-year-old-boy, suffers Aplastic anemia
Supporting examination :
• Peripheral blood count to see pancytopenia, morfology of
erythrocyte, leucocyte and thrombocyte and count the sums.
• Bone Marrow Punction to see bone marrow representation.
Management :
• Stop using Chlorampenicol
• Give supporting therapy, such as :
• Make sure the etiology of Adi’s fever, if it is caused by bactery infection,
give antibiotic, such as B-Lactam and Aminoglicoside
• Take care of self-hygiene
• Result of supporting examination :
• If Hb , 7 gr% then do transfusion of red-packed cell
• If thrombocyte < 20.000/uL then do thrombocyte transfusion
• Observation patient, wether Adi’s condition comes better. If not
do combination therapy, consist of :
• Methylprednisolon 5 mg/KgBW IV for 8 days, then tappering until 1
mg/KgBB/day for 9-14 days.
• ALG is given 40 mg/KgBW for 12 hours, continued with infuse that
combinated with Methylprednisolon.
• Siklosporin A is given 8 mg/KgBB
• Last option is Transplation of Bone Marrow
Anemia Aplastik SGD I Presentation

Más contenido relacionado

La actualidad más candente

mastocytosis_poster_edit4
mastocytosis_poster_edit4mastocytosis_poster_edit4
mastocytosis_poster_edit4
Lindsay Cox
 
Aplastic anaemia
Aplastic anaemiaAplastic anaemia
Aplastic anaemia
Nabil Chy
 

La actualidad más candente (20)

A Case of Primary Myelofibrosis
A Case of Primary MyelofibrosisA Case of Primary Myelofibrosis
A Case of Primary Myelofibrosis
 
Leukemia in Children
Leukemia in ChildrenLeukemia in Children
Leukemia in Children
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Aplastic anemia (aa)
Aplastic anemia  (aa)Aplastic anemia  (aa)
Aplastic anemia (aa)
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Disorders of myelopoiesis.ppt
Disorders of myelopoiesis.pptDisorders of myelopoiesis.ppt
Disorders of myelopoiesis.ppt
 
Aplastic anemia -medical information (definition,management, diagnosis, medic...
Aplastic anemia -medical information (definition,management, diagnosis, medic...Aplastic anemia -medical information (definition,management, diagnosis, medic...
Aplastic anemia -medical information (definition,management, diagnosis, medic...
 
mastocytosis_poster_edit4
mastocytosis_poster_edit4mastocytosis_poster_edit4
mastocytosis_poster_edit4
 
Aa
AaAa
Aa
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Aplastic Anemias & Bone Marrow Transplant I by Dr. Sookun Rajeev Kumar
Aplastic Anemias & Bone Marrow Transplant I by Dr. Sookun Rajeev KumarAplastic Anemias & Bone Marrow Transplant I by Dr. Sookun Rajeev Kumar
Aplastic Anemias & Bone Marrow Transplant I by Dr. Sookun Rajeev Kumar
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Leukemias in children
Leukemias in childrenLeukemias in children
Leukemias in children
 
Aplastic anemia 2011
Aplastic anemia 2011Aplastic anemia 2011
Aplastic anemia 2011
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Aplastic anaemia
Aplastic anaemiaAplastic anaemia
Aplastic anaemia
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
A Case of Pure Red Cell Aplasia
A Case of Pure Red Cell AplasiaA Case of Pure Red Cell Aplasia
A Case of Pure Red Cell Aplasia
 

Similar a Anemia Aplastik SGD I Presentation

Case study of thrompocytosis
Case study of thrompocytosisCase study of thrompocytosis
Case study of thrompocytosis
mohammed sediq
 
LEUKEMIA, blood disorders, blood cancerpptx
LEUKEMIA, blood disorders, blood cancerpptxLEUKEMIA, blood disorders, blood cancerpptx
LEUKEMIA, blood disorders, blood cancerpptx
mkniranda
 
Approch to Hematuria in pediatric age group
Approch to Hematuria in pediatric age groupApproch to Hematuria in pediatric age group
Approch to Hematuria in pediatric age group
Mohammed Saadi
 

Similar a Anemia Aplastik SGD I Presentation (20)

Aplastic anemia Dr Zaira Hussain
Aplastic anemia Dr Zaira Hussain Aplastic anemia Dr Zaira Hussain
Aplastic anemia Dr Zaira Hussain
 
Anemia
AnemiaAnemia
Anemia
 
thrombo done2.ppt
thrombo done2.pptthrombo done2.ppt
thrombo done2.ppt
 
thrombo done1.ppt
thrombo done1.pptthrombo done1.ppt
thrombo done1.ppt
 
Pathology of bood & Pathology of urine .pptx
Pathology of bood & Pathology of urine .pptxPathology of bood & Pathology of urine .pptx
Pathology of bood & Pathology of urine .pptx
 
Aplastic Anaemia
Aplastic AnaemiaAplastic Anaemia
Aplastic Anaemia
 
Anemia &amp; transfusion
Anemia &amp; transfusion Anemia &amp; transfusion
Anemia &amp; transfusion
 
Multiple Myeloma (Case presentation)
Multiple Myeloma (Case presentation) Multiple Myeloma (Case presentation)
Multiple Myeloma (Case presentation)
 
CHRONIC EOSINOPHILIC LEUKEMIA
CHRONIC EOSINOPHILIC LEUKEMIACHRONIC EOSINOPHILIC LEUKEMIA
CHRONIC EOSINOPHILIC LEUKEMIA
 
Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia (ITP)Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia (ITP)
 
Lab investigations in OMFS- ih
Lab investigations in OMFS- ihLab investigations in OMFS- ih
Lab investigations in OMFS- ih
 
05 SCD (1).ppt
05 SCD (1).ppt05 SCD (1).ppt
05 SCD (1).ppt
 
ITP by dr. Mohib Ali
ITP by dr. Mohib AliITP by dr. Mohib Ali
ITP by dr. Mohib Ali
 
Leukemia
LeukemiaLeukemia
Leukemia
 
Case study of thrompocytosis
Case study of thrompocytosisCase study of thrompocytosis
Case study of thrompocytosis
 
LEUKEMIA, blood disorders, blood cancerpptx
LEUKEMIA, blood disorders, blood cancerpptxLEUKEMIA, blood disorders, blood cancerpptx
LEUKEMIA, blood disorders, blood cancerpptx
 
Approch to Hematuria in pediatric age group
Approch to Hematuria in pediatric age groupApproch to Hematuria in pediatric age group
Approch to Hematuria in pediatric age group
 
Approach to anaemia
Approach to anaemiaApproach to anaemia
Approach to anaemia
 
SEPSIS By Eze A.T Final Copy.pptx
SEPSIS By Eze A.T Final Copy.pptxSEPSIS By Eze A.T Final Copy.pptx
SEPSIS By Eze A.T Final Copy.pptx
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 

Último

1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 

Último (20)

Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room service
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 

Anemia Aplastik SGD I Presentation

  • 1. Skmarina Hanna Larose S. P. Vesper J. N. Zamili Adolf Finsensius Sarumaha Agnes Meinulo Duha Alhoi Lesley Davidson Annisa Maichie Kurniasih Evie Clarensia Lase Louis Mapolo Sutian Maruli Freddy Simamora Nikko Fernando Venesia Nita Fatmasari Bangun Rosnilam Moho Siti Ramadhani Sri Wahyu Ratnasari Nasution Tiorasi Pakpahan
  • 2. Adi, a six-year-old-boy, can’t take school activities in his school for six days because of having severe fever, myalgia and anorexia, but lately, Adi’s face comes paler, his heart beats faster, malaise, lose appetite, bleeding around his gums and petechiae, ecchymosis in superficial. Adi has history of eating Chlorampenicol often and antipiretic which are bought by his mother. Hence Adi’s condition is worse, Adi is taken to pediatrician. Doctor suggests to do a complete blood examination and Bone Marrow Punction. What has happened to Adi and how is the management?
  • 3. • Myalgia : pain on muscle • Ecchymosis : patch of bleeding under skin with diameter > 2 mm • Petechiae : patch of bleeding under skin with diameter < 2 mm • Anorexia : appetite disruption • Bone Marrow Punction : an examination by doing aspiration of bone marrow liquid
  • 4. 1. Adi, a six-year-old-boy, can’t take school activities in his school for six days because of having severe fever, myalgia and anorexia, but lately, Adi’s face comes paler, his heart beats faster, malaise, lose appetite, bleeding around his gums and petechiae, ecchymosis in superficial. 2. Adi has history of eating Chlorampenicol often and antipiretic which are bought by his mother. 3. Doctor suggests to do a complete blood examination and Bone Marrow Punction.
  • 5. 1. - Probably caused by infection - Probably caused by aplastic anemia - Patient has hemostatic disfunction - Probably having thrombosis disfunction - Probably having pancytopenia 2. - Probably caused by toxin of medicines - Lack of knowledge of patient’s mom 3. To uphold the final diagnose
  • 6. Adi, a-six-year-old-boy, probably is having anemia aplastic
  • 7. 1. Classification of anemia 2. Definition of aplastic anemia 3. Etiology of aplastic anemia 4. Epidemiology of aplastic anemia 5. Classification of aplastic anemia 6. Pathophysiology of aplastic anemia 7. Clinical symptoms of aplastic anemia 8. Anamnesis of aplastic anemia 9. Physical examination of aplastic anemia 10. Supporting examination of aplastic anemia 11. Management of aplastic anemia 12. Prevention of aplastic anemia 13. Complication of aplastic anemia 14. Prognosis of aplastic anemia
  • 8. A. Based on etiopathogenesis I. Disturbance in erythrocytes formation and marrow bone a. Deficiency of essential a. Iron Deficiency b. Folic acid deficiency c. Vitamin B12 deficiency b. Disturbance in Iron utilization a. Chronic disease b. Sideroblastic anemia
  • 9. c. Marrow bone destruction a. Aplastic anemia b. Mieloptisica anemia c. Hematologic anemia d. Dyserythropoiesis anemia e. Myelodisplastic syndrome d. Deficiency of erithropoiesis II. Hemorrhagic cause III. Hemolitic cause IV. Unknown and complex pathogenesis
  • 10. B. Based on morphology I. Hypochromic microcytic II. Normochromic normocytic III. Macrocytic a. Megaloblastic b. Non-megaloblastic
  • 11. Aplastic anemia is a condition caused by decreasing of peripheral blood hematopoietic cells such as erythrocytes, leukocytes and platelets as a result of the cessation of cell production in bone marrow hemopoetic.
  • 12. a. Congenital Factor : Fanconi syndrome b. Acquired factors : • Chemicals : Benzene, insecticides, compound As, Au, Pb. • Drugs : Chloramphenicol, mesantoin (anticonvulsants), piribenzamin (antihistamines ), santonin - calomel, a drug sitostatica (myleran, methrotrexate, TEM, vincristine, rubidomycine etc. ), anti- tumor drugs (nitrogen mustard), anti- microbial. • Radiation : Roentgen rays, radioactive. • Infection : Miliary tuberculosis, hepatitis and others - others. • Malignancy : Kidney disease, endocrine disorders, and idiopathic.
  • 13. The incidence of acquired aplastic anemia varies around the world and range from 2 to 6 cases per 1 million population per year with geographic variation. Acquired aplastic anemia generally appears at the age of 15 to 25 years; peak incidence appears after the age of 60 years.
  • 14. I. Primary 1 . Congenital abnormalities 2 . Idiopathic II . Secondary : 1 . Due to radiation, chemicals, or drugs 2 . Due to other causes : a. Virus Infection : Hepatitis Viruses / other viruses b . Due to pregnancy c . Radiation
  • 15.
  • 16. 1. Tachycardia 2. Increasing of breathing frequency 3. Pale 4. Weakness 5. Dizzy 6. Nausea 7. Decreasing quality of skin and hair
  • 17. a. Complaints eritroblastopenia b. Complaints thrombocytopenia c. Complaints eukopenia d. History of treatment : • Consume drugs in a long period of time • Chemotherapy • Often exposed to radiation like x-rays and radioactive rontgen e. previous Illness History d. Family history of sitopenia
  • 18. a. Inspection : 1. Pale 2. There are bruises, petechiae, or ecchymosis 3. bleeding gums b. Palpation : 1. body temperature increase 2. cold extremities 3. tachicardy 4. Hepatomegaly (found in a several patients) c. Percussion : Hepatomegaly (found in a fraction of patients) d. Auscultation : gallop rhytm and wheezing
  • 19. 1. Laboratory Examination a. Peripheral Blood According to The International Agranulocytosis and Aplastic Anaemia Study (IAAS) is called anemia aplastik when: i. the levels of hemoglobin ≤ 10 g/dl or Hematokrit ≤ 30% ii. Count of platelets ≤ 50,000/mm3 iii. Leukocyte Count ≤ 3500/mm3 or Granulocytes ≤ 1.5 × 109/l
  • 20. 2. bone marrow Biopsy 3. Radiological Examination 1. Nuclear Magnetic Resonance Imaging 2. Radionuclide Bone Marrow Imaging (Scanning Bone Marrow)
  • 21. Diagnosis differential 1. Idiopathic Thrombocytopenic Purpura (ITP) and Thrombocytopenic Purpura Amegakaryocytic (ATP) 2. Type of aleukemik acute Leukemia, especially ALL (Acute Lymphocytic Leukemia) 3. Preleukemik Stage of acute leukemia
  • 22. Management 1. Supportive therapy 1. Leukocyte-poor red cells Transfusion (overcome anemia) 2. Platelet suspension transfusion (Overcome bleeding) 3. Antibiotics ( for infections, recommended antibiotics are b-lactam and aminoglycosides) 4. Blood, urine, faeces, sputum, CSF culture 5. Avoiding the chemical and physical toxic and drugs.
  • 23. 2. Medication Therapy 1. Androgen Oksimetolon is better instead of testosteron, with dose 1-2 mg/kg/day 2. Imunosuppressive a. Methylprednisolon ( 5 mg/kg IV 8 days then tappering) b. Antilymphocyte-Globulin (40mg/kg IV for 12hours +methylprednisolon 1mg/kg/hours IV for 4 days) c. Antithymocyte-Globulin (100-2000mg/kg IV) d. Cyclosporin A (8mg/kg/day PO for 14 day continue with 15mg/kg/day) e. Cyclophosphamide (50mg/kg/day for 4 days, still controversy) 3. Growth factor ( G-CSF with dose 5 ig/kg/day)
  • 24. 4. Combination therapy combination of ALG/ATG, methylprednisolon and CsA. 3. Blood Transfusion 4. Chelation Therapy given when there is accumulation of iron due to blood transfusion 5. bone marrow transplant 6. Food 7. Rest Relaps in case of relaps then can be given CsA and if unsuccessful then can be given repeat ATG
  • 25. Prevention 1. Avoiding toxic materials 2. Avoiding drugs consumption which can trigger aplastic anemia 3. Avoiding radiation 4. Good hygiene 5. Management of bleeding and infection
  • 26. 1. Infection 2. Bleeding 3. GVHD after transplantation 4. Death
  • 27. Based on : 1. Bone Marrow representation 2. HbF > 200 mg% give a better prognosis 3. Granulocyte > 2000/mm3 give better prognosis 4. Secondary infection prevention
  • 28. Diagnose : Adi, 6-year-old-boy, suffers Aplastic anemia Supporting examination : • Peripheral blood count to see pancytopenia, morfology of erythrocyte, leucocyte and thrombocyte and count the sums. • Bone Marrow Punction to see bone marrow representation. Management : • Stop using Chlorampenicol • Give supporting therapy, such as : • Make sure the etiology of Adi’s fever, if it is caused by bactery infection, give antibiotic, such as B-Lactam and Aminoglicoside • Take care of self-hygiene
  • 29. • Result of supporting examination : • If Hb , 7 gr% then do transfusion of red-packed cell • If thrombocyte < 20.000/uL then do thrombocyte transfusion • Observation patient, wether Adi’s condition comes better. If not do combination therapy, consist of : • Methylprednisolon 5 mg/KgBW IV for 8 days, then tappering until 1 mg/KgBB/day for 9-14 days. • ALG is given 40 mg/KgBW for 12 hours, continued with infuse that combinated with Methylprednisolon. • Siklosporin A is given 8 mg/KgBB • Last option is Transplation of Bone Marrow